Maryanne Godbout, CNS | |
2545 Schoenersville Rd, Bethlehem, PA 18017-7300 | |
(610) 866-9000 | |
Not Available |
Full Name | Maryanne Godbout |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
Location | 2545 Schoenersville Rd, Bethlehem, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528013505 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | RN312026L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maryanne Godbout, CNS Po Box 1754, Allentown, PA 18105-1754 Ph: () - | Maryanne Godbout, CNS 2545 Schoenersville Rd, Bethlehem, PA 18017-7300 Ph: (610) 866-9000 |
News Archive
The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago - but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.
A review article published in the July/August 2005 Journal of Infusion Nursing examines the need for established treatment guidelines to support doctors and nurses in correctly dosing and administering intravenous immunoglobulin (IVIG) as replacement therapy in patients with primary immunodeficiency (PI) disorders, who do not produce adequate levels of antibodies essential in fighting infectious diseases.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Experiments conducted under the leadership of a Stanford University School of Medicine investigator have succeeded, for the first time, in restoring multiple key aspects of vision in mammals.
› Verified 5 days ago
Patricia Fuisz, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2710 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-297-7500 Fax: 610-297-7533 |